Unknown

Dataset Information

0

Octamer-dependent transcription in T cells is mediated by NFAT and NF-κB.


ABSTRACT: The transcriptional co-activator BOB.1/OBF.1 was originally identified in B cells and is constitutively expressed throughout B cell development. BOB.1/OBF.1 associates with the transcription factors Oct1 and Oct2, thereby enhancing octamer-dependent transcription. In contrast, in T cells, BOB.1/OBF.1 expression is inducible by treatment of cells with PMA/Ionomycin or by antigen receptor engagement, indicating a marked difference in the regulation of BOB.1/OBF.1 expression in B versus T cells. The molecular mechanisms underlying the differential expression of BOB.1/OBF.1 in T and B cells remain largely unknown. Therefore, the present study focuses on mechanisms controlling the transcriptional regulation of BOB.1/OBF.1 and Oct2 in T cells. We show that both calcineurin- and NF-κB-inhibitors efficiently attenuate the expression of BOB.1/OBF.1 and Oct2 in T cells. In silico analyses of the BOB.1/OBF.1 promoter revealed the presence of previously unappreciated combined NFAT/NF-κB sites. An array of genetic and biochemical analyses illustrates the involvement of the Ca(2+)/calmodulin-dependent phosphatase calcineurin as well as NFAT and NF-κB transcription factors in the transcriptional regulation of octamer-dependent transcription in T cells. Conclusively, impaired expression of BOB.1/OBF.1 and Oct2 and therefore a hampered octamer-dependent transcription may participate in T cell-mediated immunodeficiency caused by the deletion of NFAT or NF-κB transcription factors.

SUBMITTER: Mueller K 

PROVIDER: S-EPMC3575799 | biostudies-literature | 2013 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications


The transcriptional co-activator BOB.1/OBF.1 was originally identified in B cells and is constitutively expressed throughout B cell development. BOB.1/OBF.1 associates with the transcription factors Oct1 and Oct2, thereby enhancing octamer-dependent transcription. In contrast, in T cells, BOB.1/OBF.1 expression is inducible by treatment of cells with PMA/Ionomycin or by antigen receptor engagement, indicating a marked difference in the regulation of BOB.1/OBF.1 expression in B versus T cells. Th  ...[more]

Similar Datasets

| S-EPMC10725083 | biostudies-literature
| S-EPMC4076808 | biostudies-literature
| S-EPMC4587297 | biostudies-literature
| S-EPMC4661856 | biostudies-literature
| S-EPMC4054419 | biostudies-literature
| S-EPMC3268328 | biostudies-literature
| S-EPMC8277743 | biostudies-literature
| S-EPMC3372649 | biostudies-literature
| S-EPMC3443185 | biostudies-literature
| S-EPMC6369451 | biostudies-literature